A less common bivalent class of gain-of-function (GOF) missense mutations observed in multiple Vav1 domains culminate in Rac1 and NFAT activation, but do not affect Notch inhibition, and are also observed in PTCL, NOS (and other T-cell lymphomas). This evidence concerns the gene RAC1 and T-cell non-Hodgkin lymphoma.